These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2065270)

  • 21. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
    Schulz-Wendtland R; Krämer S; Keilholz L; Pflüger S; Lang N
    Strahlenther Onkol; 1996 Aug; 172(8):439-45. PubMed ID: 8765347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of effects of radiation therapy on the cervical cancer by local responce.
    Yamashita M; Fujiwara A
    Hiroshima J Med Sci; 1977 Dec; 26(4):303-9. PubMed ID: 615177
    [No Abstract]   [Full Text] [Related]  

  • 23. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
    Oka K; Suzuki Y; Nakano T
    Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix.
    Konishi I; Fujii S; Nonogaki H; Nanbu Y; Iwai T; Mori T
    Cancer; 1991 Sep; 68(6):1340-50. PubMed ID: 1651807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor growth fraction in cervical carcinoma.
    Wong WS; McGuire LJ
    Gynecol Oncol; 1991 Jan; 40(1):48-54. PubMed ID: 1989915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67.
    Wong FW
    Gynecol Obstet Invest; 1994; 37(2):123-6. PubMed ID: 8150368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck.
    Grénman R; Carey TE; McClatchey KD; Wagner JG; Pekkola-Heino K; Schwartz DR; Wolf GT; Lacivita LP; Ho L; Baker SR
    Cancer; 1991 Jun; 67(11):2741-7. PubMed ID: 2025837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation.
    Garg AK; Jhingran A; Klopp AH; Aggarwal BB; Kunnumakkara AB; Broadus RR; Eifel PJ; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1331-6. PubMed ID: 20231067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological and immunohistochemical prediction for local control of cervical squamous cell carcinoma treated with radiotherapy alone.
    Nakano T; Oka K; Arai T
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):1011-9. PubMed ID: 2211239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
    Sahin AA; Ro J; Ro JY; Blick MB; el-Naggar AK; Ordonez NG; Fritsche HA; Smith TL; Hortobagyi GN; Ayala AG
    Cancer; 1991 Aug; 68(3):549-57. PubMed ID: 1648433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care.
    Hata M; Koike I; Miyagi E; Asai-Sato M; Kaizu H; Mukai Y; Takano S; Ito E; Sugiura M; Inoue T
    Anticancer Res; 2018 Feb; 38(2):1033-1040. PubMed ID: 29374737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The comparison of radiosensitivity between uterine cervical squamous carcinoma and adenocarcinoma].
    Zhang M; Cai S; Shi D
    Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):611-3. PubMed ID: 10806688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy.
    Cerciello F; Hofstetter B; Fatah SA; Zaghloul M; Odermatt B; Bodis S; Varga Z; Pruschy M; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1390-8. PubMed ID: 16029798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytopathological and immunohistochemical study for estimating radiotherapeutic effects in uterine cervical cancer.
    Begum M
    Hiroshima J Med Sci; 1993 Jun; 42(2):53-65. PubMed ID: 8253599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
    Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
    Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy.
    Chaopotong P; Kajita S; Hashimura M; Saegusa M
    J Clin Pathol; 2012 May; 65(5):424-30. PubMed ID: 22389513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose delivered to the lumbosacral plexus from high-dose-rate brachytherapy for cervical cancer.
    Rash D; Durbin-Johnson B; Lim J; Dieterich S; Huddleston A; Yi S; Mayadev J
    Int J Gynecol Cancer; 2015 Jun; 25(5):897-902. PubMed ID: 25768077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
    Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
    Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.